SUO 2018 Prostate Cancer

Viewing 1-20 of 29 articles

SUO 2018: PSMA-Guided Salvage Lymph Node Dissection

SUO 2018: PROTUX Clinical Trial: Rituximab Neoadjuvant Therapy in High Risk Prostate Cancer Patients Scheduled to Undergo Radical Prostatectomy

SUO 2018: Gene Expression Classifier Utility in Men at High Risk of Recurrence Following Radical Prostatectomy (G-MINOR)

SUO 2018: Pathologic Progression is the Dominant Driver of Conversion to Radical Therapy Post Vascular

SUO 2018: Lithium Treatment Alters Histone Lysine Modification in Prostate Cancers

SUO 2018: Treatment of the Primary Is Not Necessary, or Is It?

SUO 2018: Long-term Outcomes of Active Surveillance for Prostate Cancer – The Memorial Sloan Kettering Cancer Center Experience

SUO 2018: Post-Operative Opioid Prescribing in Urology: Are We Contributing to The National Crisis?

SUO 2018: Qualitative and Quantitative Evidence of Sipuleucel-T Induced PAP and PA2024 Specific CD8+ Cytolytic Response and its Association with Overall Survival

SUO 2018: Changing Practice in High Risk Prostate Cancer Using Novel Trial Design: The STAMPEDE Study

SUO 2018: Impact of Robotics - The Changing Face of Urologic Oncologic Surgery from 2000-2018

SUO 2018: Adaptive Survival Pathways – AR Variants and Autophagy

SUO 2018: Uptake on PSMA Targeted Alpha Emitters in mCRPC

SUO 2018: Signal Transduction Pathways – ADT + AKT trials

SUO 2018: Long-term PROS with Abiraterone Acetate+prednisone Added to ADT in Newly-diagnosed Metastatic Castration-naïve Prostate Cancer: Second Interim Analysis of the Latitude Study

SUO 2018: A Statistical Analyses of the PROSPER Study by Prior Definitive Surgery

SUO 2018: DNA Damage Response – ADT + PARPi

SUO 2018: The PROSPER Trial, A Post Hoc Analysis by Prior Definitive Surgery

SUO 2018: PSMA-Guided Metastasis Directed Radiation

SUO 2018: Targeting the Adaptive Molecular Landscape of Castration-Resistant Prostate Cancer

1
2